The larvae of calliphorid flies are used to debride wounds of patients with severe tissue destruction, often concurrently with antimicrobials. The current study evaluates the effects of ceftazidime, tobramycin, amikacin, gentamicin, polymyxin B, doxycycline, paromomycin, amphotericin B, sodium stibogluconate, and miltefosine at 1,10, and 100× the Maximum Clinical Concentration (mg/kg/d) in raw liver assays. Effects on larvae were small and depended on dose and antimicrobial formulation, with hours in assay (24 or 48 h) having a significant effect on larval survival. Sodium stibgluconate had the strongest effect on maggot survival (80.0% at 48 h). These results suggest that the antimicrobials tested here may be used simultaneously with maggot debridement therapy, and may actually increase the effectiveness of maggot debridement therapy in certain applications where >1 × Maximum Clinical Concentration is indicated, such as topical creams for cutaneous leishmaniasis.
How to translate text using browser tools
1 September 2012
Biocompatibility of Antimicrobials to Maggot Debridement Therapy: Medical Maggots Lucilia sericata (Diptera: Calliphoridae) Exhibit Tolerance to Clinical Maximum Doses of Antimicrobials
George W. Peck,
Benjamin C. Kirkup
ACCESS THE FULL ARTICLE
It is not available for individual sale.
This article is only available to subscribers.
It is not available for individual sale.
It is not available for individual sale.
![](/ContentImages/journals/ment/49/5/5/WebImages/033.049.0500.cover.gif)
Journal of Medical Entomology
Vol. 49 • No. 5
September 2012
Vol. 49 • No. 5
September 2012
antibacterial
antifungal
antileishmanial
Lucilia sericata
maggot therapy